Description  Claims  Drawing  Cited references 

US62714238   [0001] 
US20080248028A1   [0024] 
US8609816B2   [0072] 
US8097703B2   [0072] 
US8481683B2   [0072] 
US7387776B2   [0072] 
US8124738B2   [0072] 
US6984720B1   [0072] 
US8008449B2   [0072] 
US20090297438A1   [0072] 
US7875278B2   [0072] 
US8222375B2   [0072] 
US7335748B2   [0072] 
US8268970B2   [0072] 
US20100092484A1   [0072] 
US8258266B2   [0072] 
US8450464B2   [0072] 
US7943743B2   [0072] 
US7521541B2   [0077] 
US4698420A   [0077] 
US7311902B2   [0077] 
US62270245   [0077] 
US8865875B2   [0077] 
US7402556B2   [0082] 
US7425541B2   [0082] 
US6897034B2   [0082] 
US8664407B2   [0086]  [0098] 
WO8101145A   [0096] 
US6214345B1   [0096] 
US7691962B2   [0096]  [0098] 
US20080279868A1   [0096]  [0098] 
WO2008083312A2   [0096] 
US7375078B2   [0096] 
US8039273B   [0096] 
US20030096743A1   [0096] 
US7087600B2   [0098] 
US6989452B2   [0098] 
US7129261B2   [0098] 
WO02096910A1   [0098] 
US7517903B2   [0098] 
US7714016B2   [0098] 
US7847105B2   [0098] 
US7968586B2   [0098] 
US8461117B2   [0098] 
US8980824B2   [0105] 
WO2008030612A2   [0108] 
US20100093024A1   [0108] 
US20130230543A1   [0111] 
WO2016144608A1   [0111] 
WO2017059158A1   [0112] 
US20090318349A1   [0113] 
US20100099610A1   [0113] 
US20100087371A1   [0113] 
WO2010087994A2   [0117] 
WO2005051976A2   [0117] 
US20170166384A1   [0125] 
US20130028857A1   [0126] 
US20120003298A1   [0197] 
US20140323441A1   [0197] 
US20150299221A1   [0197] 
US20160304531A1   [0197] 
US20130202629A1   [0197] 
US8729088B2   [0197] 
US9050376B2   [0197] 
US20160199499A1   [0197] 
US7919498B2   [0197] 
US9662336B2   [0197] 
US20170121421A1   [0197] 
US9944649B2   [0197] 
WO2007028129A1   [0197] 
US9127006B2   [0197] 
WO2016107536A1   [0197] 
US20170273983A1   [0197] 
WO2017076346A1   [0197] 
US8993755B2   [0197] 
US9161934B2   [0197] 
US20090118263A1   [0197] 
US20190055246A1   [0197] 
US20190055247A1   [0197] 
US6028076A   [0197] 
US20120083473A1   [0197] 
US6376501B1   [0197] 
JP2004137157B   [0197] 
US7521454B2   [0197] 
US20090105212A1   [0197] 
US20110028715A1   [0197] 
US8148371B2   [0197] 
WO2015036044A1   [0197] 
US7691877B2   [0197] 
US20120302598A1   [0197] 
US7241890B2   [0197] 
US9902730B2   [0197] 
US9295732B2   [0197] 
US9173935B2   [0197] 
US20160168150A1   [0197] 
US9499549B2   [0197] 
US20070225303A1   [0197] 
WO2019124500A1   [0197] 
WO2017216293A1   [0197] 
US20190055243A1   [0197] 
US20190055245A1   [0197] 
US2869719W   [0197] 
US7642350B2   [0197] 
US20140141033A1   [0197] 
US20190055244A1   [0197] 
WO2018095426A1   [0197] 
US20120231023A1   [0197] 

Cellular and Molecular Immunology   [0023] 
Nature   [0023] 
Science   [0023] 
Proc. Natl. Acad. Sci. USA   [0023] 
Sequences of proteins of immunological interest   [0024]  [0110] 
Cancer Res.   [0071] 
Adv. Drug Delivery Rev   [0074] 
Pharmacology & Therapeutics   [0074] 
Biochemistry   [0077] 
Cancer Res.   [0077]  [0077] 
Nature Biotechnol.   [0077] 
Bioconjugate Chem.   [0077] 
J. Biol. Chem.   [0077] 
J. Biol. Chem.   [0077] 
J. Biol. Chem.   [0077] 
Nature Biotechnology   [0077] 
J. Immunol.   [0077] 
Bioconjugate Chem.   [0077] 
Protein Engineering   [0077] 
Protein Engineering Design & Selection   [0077] 
Science   [0081] 
Meth. Enzymol.   [0081] 
Meth. Enzymol   [0081] 
Meth. Enzymol.   [0081] 
Meth. Enzymol   [0081] 
Meth. Enzymol.   [0081] 
Meth. Enzymol.   [0081] 
Biorg. Med. Chem. Lett   [0083] 
Bioorg. Med. Chem. Lett.   [0083] 
Bioconjugate Chem.   [0083] 
J. Med. Chem.   [0096] 
Pharmacology & Therapeutics   [0096] 
J. Org. Chem.   [0096] 
Nature Biotechnology   [0096] 
J. Amer. Chem. Soc.   [0107] 
Biochemistry   [0107] 
Biotechnol. Bioeng.   [0108] 
Angew. Chem. Int. Ed.   [0109] 
PLoS One   [0117] 
Biotechnol. Lett.   [0117] 
J. Controlled Release   [0119] 
J. Pharmaceutical Sci   [0120] 
Prog. Polymer Sci.   [0120] 
Polymer Chem.   [0121] 
Remington: The Science and Practice of Pharmacy   [0130] 
Sustained and Controlled Release Drug Delivery Systems   [0137] 
Facile syntheses of functionalized toll-like receptor 7 agonists   [0197] 
Synthesis and immunostimulatory activity of substituted TLR7 agonists   [0197] 
Identification of High-Potency Human TLR8 and Dual TLR7/TLR8 Agonists in Pyrimidine-2,4-diamines.   [0197] 
Natural and Synthetic TLR7 Ligands Inhibit CpG-A- and CpG-C-Oligodeoxynucleotide-Induced IFN-α Production.   [0197] 
Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates   [0197] 
Synthesis and Characterization of PEGylated Toll Like Receptor 7 Ligands.   [0197] 
Recent Advances in Small-Molecule TLR7 Agonists for Drug Discovery   [0197] 
Targeted Activation of Toll-Like Receptors: Conjugation of a Toll-Like Receptor 7 Agonist to a Monoclonal Antibody Maintains Antigen Binding and Specificity.   [0197] 
2,4-Diaminoquinazolines as Dual Toll Like Receptor (TLR) 7/8 Modulators for the Treatment of Hepatitis B Virus.   [0197] 
Synthesis and Biological Evaluation of Novel 9-Substituted-8-Hydroxyadenine Derivatives as Potent Interferon Inducers.   [0197] 
Intratracheal and oral administration of SM-276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer.   [0197] 
Recognition of single-stranded RNA viruses by Toll-like receptor 7   [0197] 
Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B.   [0197] 
Small-Molecule Interferon Inducers. Toward the Comprehension of the Molecular Determinants through Ligand-Based Approaches.   [0197] 
Synthesis and evaluation of 8-oxoadenine derivatives as potent Toll-like receptor agonists with high water solubility.   [0197] 
Combination Immunotherapy with TLR Agonists and Checkpoint Inhibitors Suppresses Head and Neck Cancer   [0197] 
The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy   [0197] 
The Use of Toll-like Receptor 7/8 Agonists as Vaccine Adjuvants   [0197] 
Toll-Like Receptor 7 Agonists: Chemical Feature Based Pharmacophore Identification and Molecular Docking Studies.   [0197] 
Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA.   [0197]